Oral Ecnoglutide for overweight or obesity
Part of Hormones & metabolism clinical trials.
This trial tests an oral medication called Ecnoglutide to help people with overweight or obesity lose weight. It is for Chinese adults who are not diabetic and have a stable weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your BMI must be between 24 and 35, and you must weigh more than 60 kg (men) or 50 kg (women).
- Your weight should have stayed about the same (changed less than 5%) in the last 3 months.
- You cannot have certain hormone-related conditions like Cushing's syndrome, thyroid problems, or a family history of certain thyroid cancers.
- You must not have had a stroke, heart attack, heart failure, or serious heart rhythm problem in the past 6 months.
- You cannot have serious stomach or bowel conditions, or have had major stomach surgery (except gallbladder or appendix removal).
- Your blood sugar must be in the normal range (not in the diabetes range).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called elecoglipron to see if it helps people with obesity or overweight lose weight. It may be an option if you have a high body mass index or weight-related health issues like high blood pressure or prediabetes.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study is testing two weight-loss medications: liraglutide alone or combined with orlistat. It is for adults who are overweight or obese and have certain related health conditions like high blood pressure or type 2 diabetes. The goal is to see which treatment works better for long-term weight loss.
This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Hear when a new Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.